Recital 14, Regulation (EU) 2025/117

In forcesince 24 Jan 2025

To reduce administrative burden and avoid duplication, where joint scientific consultations on medical devices are conducted in parallel with the expert panel consultation, the health technology developer should submit the same documentation to the HTA secretariat and to the expert panel. For this purpose, before establishing the template of the briefing package pursuant to Article 21, point (b), of Regulation (EU) 2021/2282 to be used where the joint scientific consultation on medical devices is carried out in parallel with the expert panel consultation, the Coordination Group should consult and reach agreement with the European Medicines Agency, in consultation with the expert panels, on the template.